Founded in 2003 on the 3500m Hongyuan Plateau of Sichuan, Yutuo Tibetan Medicine carries forward the therapeutic system of The Four Medical Tantras, the classic Tibetan medical masterpiece. We are the only national high-tech Tibetan medicine enterprise in the Sichuan Tibetan region that has passed the latest GMP certification and maintains normal production.
We operate a complete industrial ecosystem with ten-thousand-mu Tibetan herb cultivation bases, covering integrated R&D, production, domestic distribution and cross-border trade of Tibetan medicines and highland nutritional health foods. We perfectly combine ancient Tibetan Monarch-Minister-Assistant-Guide formulation rules with modern nutritional science. Utilizing authentic local highland ingredients such as Hongyuan yak, Amla and Maca, we develop a full range of natural functional foods, including yak bone collagen oligopeptides, GABA sleep-aid solid drinks, Maca & yak penis tonic tablets.
Backed by an academician workstation and professional R&D team, we implement full-chain quality control. Adhering to natural, mild and food-medicine homologous formulas, we are dedicated to bringing original ecological plateau dietary supplements to global consumers.

founded in 2020 and located in Ziyang, Sichuan—the "China Dental Valley"—is a modern, comprehensive high-tech pharmaceutical enterprise integrating medical research, development, production and sales. Focusing on the oral healthcare sector, the company is dedicated to the industrialization and commercialization of cutting-edge oral medical technologies.

The company's core business encompasses the production and sales of Class I and Class II medical devices, as well as the R&D of technological systems for dental caries preventation and repair. Demonstrating robust product capabilities, the company has successfully transformed top-tier scientific achievements from the West China School of Stomatology, Sichuan University, into Class II medical devices such as "Aichijian Medical Anti-caries Toothpaste." Currently, the company holds 8 Class I and 9 Class II medical device registration certificates. With seven mature production lines and over a hundred production and testing units, it possesses a proven system for technology transfer and strong industrialization capabilities.

Sichuan Neijiang Huixin Pharmaceutical Co., Ltd. was set up by a workshop of the former Neijiang Maoshi Sugar Factory in 2002, and passed GMP certification of the earliest batch of pharmaceutical enterprises, Has passed national GMP certification many times. Since 2009 Huixin has been approved as a national high-tech enterprises. So far, the enterprise has 4 independent national invention patents ,13 utility model patents. Among them, The company's "Gold Mountain" brand in the United Kingdom, the United States, Germany, Denmark, Russia, Israel, Australia, Singapore, Japan, South Korea, India, the Czech Republic, Ukraine, Vietnam more than 10 countries registered protection, And exported to these countries, Vitamin D2 products registered in India, Russia, KOSHER and HALAL certification has been obtained. Vitamin D2 series products have won many international and domestic quality products awards, The National Food Additives Fair won the "Feitian Award ", Also listed by the Ministry of Science and Technology, By the French Science and Technology quality Supervision and Evaluation Commission as a high-quality science and technology products and received a certificate recommended to the European Union. The company submitted UDMF documents to the American FDA in 2009, UDMF registered in 2010, Registration number :23727.

Chengdu Sani Medical Equipment Co., Ltd pioneered fully automated production across its core product lines. From the in-house design and automated production of manual files, to the fully automated manufacturing of diamond burs, and to the earliest domestically developed nickel-titanium rotary files with in-house design and automated production, Chengdu Sani Medical Equipment Co., Ltd leads the intelligent transformation of dental instrument manufacturing.

After two years of research and development, we successfully launched bioceramic-coated gutta-percha points and became the first company in China to obtain EU MDR CE certification for this product, marking a significant step in aligning our innovation quality with international standards. Furthermore, in the production process of gutta-percha points, we have achieved a revolutionary leap from traditional manual methods to fully automated, standardized production. This technological breakthrough has not only increased production capacity by orders of magnitude but also ensured more precise dimensional accuracy, taper, and consistency of the products.

Designed and constructed in compliance with international cGMP standards, Shuode Pharmaceutical deeply integrates pharmaceutical manufacturing with information technology to realize digital and intelligent management of the entire drug production process. Adhering to the strategic vision of intelligence, internationalization and differentiation, the company has established full-chain quality control capabilities covering the whole lifecycle of pharmaceuticals from R&D to commercialization, and built 8 modern preparation production lines for tablets, capsules, small-volume injections, pre-filled syringes, nasal sprays and other dosage forms. To date, the company has realized the industrialization of exclusive or first generic drugs including Norepinephrine Bitartrate Injection, Ibuprofen Injection, and Bisoprolol Amlodipine Tablets. Its pharmaceutical quality management system has obtained U.S. FDA certification, and products such as Nalmefene Hydrochloride Injection, Nicardipine Hydrochloride Injection and Methylene Blue Injection have been approved for marketing in the United States.

Chengdu Anke Xing Technology Co., Ltd. and its subsidiary, Chengdu Eastern New Area Biomaterials (Medical Device) Industrial Technology Research Institute, are led by Professor Zhang Xingdong, an academician of the Chinese Academy of Engineering and a foreign member of the US National Academy of Engineering. The company has brought together top technical experts and industrial professionals from China and the United States, and is committed to addressing global technological challenges and developing original innovative solutions.

The company has established in-depth strategic cooperation with the National Engineering Research Center for Biomedical Materials. Relying on its advanced biomedical material testing and evaluation platform, the company has achieved a diversified product portfolio, fully customized biomedical material solutions, and breakthroughs in the production technologies of absorbable and degradable materials for aesthetic medicine and cosmetics, including customization of molecular weight, chemical structure, chemical composition, and terminal groups. The production capability has been expanded from gram-scale to hundred-kilogram-scale, giving the company strong international competitiveness.

Founded in 1994, Chengdu Yingde Bio is a technology-oriented enterprise dedicated to serving the fields of blood products and human vaccines. After years of development, its service scope has gradually expanded to biological product sectors including veterinary vaccines, gene therapy & monoclonal antibodies, sterile preparations, and medical aesthetics.

In 2014, Yingde Bio joined Shandong Xinhua Medical Group. Supported by robust resource integration from Xinhua Pharmaceutical Technology Group together with its own steady growth, the company has evolved into a full EPC solution provider delivering integrated services covering process technology, pharmaceutical engineering design, core process equipment manufacturing, project installation and implementation, validation, as well as operation & maintenance.

Sichuan Shuzhong Pharmaceutical Co., Ltd. Founded in July 1997, the company is located in Mazhu Town, Shifang City, Sichuan Province. It covers a land area of 74 mu with a registered capital of RMB 50 million.

The company is equipped with a Chinese herbal raw material pretreatment workshop, general formulation workshop and liquid formulation workshop, together with supporting facilities including an inspection center, warehouses, sewage treatment station and office buildings. It boasts sound production hardware, complete auxiliary facilities and rationally arranged production processes.

In January 2015, the enterprise was incorporated into Shuzhong Group as its wholly-owned subsidiary. Subsequent upgrades and renovations were carried out on its factory buildings, supporting facilities and production equipment, enabling a monthly output of 60,000 to 70,000 product cases. The company currently employs over 190 staff, among whom mid-level and senior technical personnel account for 29.2%.

It owns an abundant product portfolio consisting of 65 varieties with 86 drug approval numbers, covering capsules, granules, tablets, mixtures, syrups and active pharmaceutical ingredients (APIs).

Founded in 2007, Chengdu Dixin Animal Health Co., Ltd. is China’s first professional manufacturer of Halquinol. After nearly two decades of continuous development, the company has established an integrated production base covering the production of the core raw material 8-Hydroxyquinoline and finished Halquinol products. It has achieved independent production of both raw materials and finished products, providing stable and reliable product supply for customers worldwide.

With reliable product quality, competitive cost advantages, and a professional and efficient customer service system, the company’s products have been exported to numerous countries and regions, including Thailand, Vietnam, Malaysia, Bangladesh, Colombia, Brazil, Peru, and Ecuador.

Established in 2018, Chengdu Fengke Biotechnology Co., Ltd. focuses on the R&D, cultivation, processing, sales, and export of edible and medicinal fungi. It is a high-tech agricultural enterprise specializing in industrialized production.

The company’s leading products are white beech mushrooms and seafood mushrooms. It has obtained certifications including HACCP, GLOBAL GAP, ISO9001, and ISO22000, and possesses internationally advanced and domestically leading intelligent cultivation technologies and facilities. Its marketing network covers 57 countries worldwide, with 60% of its products exported to markets including Singapore, Thailand, Vietnam, the United States, and the European Union. The export volume of its seafood mushrooms and white beech mushrooms ranks first in China.

Hanchen Guangyi specializes in the R&D of intelligent automation technologies within the life science industry, striving to deliver state-of-the-art solutions for agricultural breeding, biomanufacturing, pharmaceutical R&D, chemical synthesis and other sectors.

The company has independently developed a full range of core biological breeding instruments, covering high-throughput genotyping systems, fully automated all-in-one devices for nucleic acid extraction and library preparation, and benchtop high-throughput molecular testing laboratories. It has successfully broken foreign technological monopolies and realized domestic substitution breakthroughs in key equipment, serving many leading enterprises both domestically and internationally. To date, the company holds over 150 core patents and strictly implements the ISO 9001 Quality Management System. Its products have been granted authoritative certifications including China NMPA approval and EU CE certification, providing compliant and reliable technical support for customers across the globe.

Chengdu Huihezheng Technology Development Co., Ltd.,  founded in 2019, is a high-tech enterprise specializing in school furniture, office furniture, medical furniture and other sectors.

The company has obtained ISO 9001 Quality Management System Certification and ISO 14001 Environmental Management System Certification. It boasts robust supply chain integration capabilities and extensive experience in cross-border trade. In recent years, the firm has vigorously expanded into global markets, with its products sold to Southeast Asia, the Middle East and other regions worldwide.

Founded in 2015, Chengdu Huisheng Technology Co., Ltd. is a high-tech medical enterprise established by a team of university research experts, clinical medical specialists and professionals with long-term dedication to ultrasonic technology research and development. The company integrates design, R&D, production, sales and after-sales services.

Our products are applicable to emergency examinations in hospitals (Emergency Department, ICU, ambulances, field rescue scenarios), bedside diagnosis and treatment (ward rounds, fetal monitoring, musculoskeletal rehabilitation examinations, fracture assessment), and physical examination preliminary screening (hospital physical check-ups, grassroots medical outreach, carotid artery screening, family planning examinations, home doctor door-to-door visits). Additionally, they serve as visual guidance instruments for venipuncture during injection and infusion, anesthetic puncture intervention, PICC catheterization and various surgical procedures. Our products are widely favored by clinical departments of domestic hospitals and primary medical institutions across China.

1. Endoscopic Surgical Power System

Strong independent R&D and production capabilities: Obtained the NMPA (National Medical Products Administration) registration certificate in 2025 and mastered core technologies.

Segmented products are accurately adapted to 6 high-precision surgical fields, including orthopedic spine surgery, otorhinolaryngology, sports medicine, neurosurgery, gynecology, and urology, to meet diverse clinical needs.

2. Third-Party Maintenance Service for Endoscopic Surgical Equipment

Comprehensive maintenance support: Equipped with a team of senior engineers and a rapid response mechanism, covering maintenance services for mainstream brand equipment.

Efficient operation and maintenance ensure the equipment is always in normal working condition, saving troubles and efforts for medical institutions.

3. Supply of Standardized Accessories

Strict selection of accessories: Provide high-quality standardized accessories with strong compatibility and high reliability.

Founded in 1998, the company is an outstanding enterprise focused on the field of medical specimen collection. It is committed to providing medical institutions with one-stop product supply services for medical specimen collection systems as well as full-process comprehensive solutions.

The enterprise currently holds 68 patented technologies, including 12 invention patents. It has established and consistently maintained a standardized quality management system, and obtained ISO 13485 Medical Devices Quality Management System Certification and CE Product Certification, which guarantees the safety and compliance of its products.

Its core product portfolio covers specimen collection products, microbial products, laboratory consumables, and auxiliary laboratory instruments. These items are widely applied in hospitals, centers for disease control and prevention, blood stations, physical examination centers, healthcare institutions, pharmaceutical and medical device manufacturers, scientific research institutes, educational establishments and other sectors. Boasting an efficient sales team and a comprehensive network of sales outlets, the company exports its products to more than 90 countries across the globe.

Chengdu Tuolan Precision Medical Technology Co., Ltd. is a medical technology enterprise dedicated to the research & development, production and commercial application of complete intracranial pressure (ICP) monitoring solutions. Committed to intensive innovation in neuromonitoring technologies, the company relies on self-developed innovative products to deliver accurate, real-time intracranial pressure assessment tools for clinical settings of intensive care and neurosurgery.

The company focuses on the development of high-performance intracranial pressure sensors and intracranial pressure monitoring systems. Its devices can generate stable, precise and uninterrupted monitoring data, assisting clinicians in formulating timely diagnosis and treatment plans and improving patient prognosis.

Continuously catering to the growing clinical demands of neurosurgery, neurological critical care, emergency medicine and Intensive Care Units (ICUs), the company integrates cutting-edge technological innovation with frontline clinical experience to develop safe, efficient and user-friendly monitoring solutions, so as to continuously advance the diagnosis and treatment capacity of neurology.

Focusing on the high-end medical equipment track, Changfeng Medical has built western China’s first digital intelligent production line for ventilators and anesthesia machines. The company’s core products include ventilators, anesthesia machines, nitric oxide therapeutic apparatuses, operating tables, surgical shadowless lamps, surgical pendants and other key operating room equipment. In addition, it offers one-stop integrated solutions such as digital operating room construction and operating room purification projects. Boasting complete supporting industrial chain capabilities, the enterprise can deliver comprehensive one-stop operating room solutions for medical institutions at all levels, supporting the upgrading of regional medical infrastructure.

Mianyang Xianfeng Medical Instrument Co., Ltd. is a professional manufacturer of medical ultrasound equipment located in the High-Tech Industrial Development Zone of Mianyang, China. With more than 20 years of experience in R&D, manufacturing, and export, the company established Mianyang Xianfeng Ultrasound Trading Co., Ltd. to expand its global business and better serve international customers.

The company specializes in the R&D and production of B-mode ultrasound scanners and color Doppler ultrasound systems for human and veterinary applications. Supported by an experienced R&D team, the company continuously advances its technologies, evolving from early mechanical and electronic ultrasound systems to high-precision full-digital beamforming ultrasound diagnostic equipment.

The company’s product portfolio includes grayscale ultrasound scanners and color Doppler systems, which are widely used in hospitals, clinics, community healthcare centers, and veterinary practices. The company also provides technical support, customized design, and OEM/ODM manufacturing services to meet diverse customer requirements.

Sichuan Defeng Pharmaceutical Co., Ltd. is located in Meishan Economic Development Zone New Area, Sichuan Province. It is a wholly-owned subsidiary of Yifan Pharmaceutical Co., Ltd., a listed company. With a registered capital of RMB 130 million and a site area of 73 mu, the company focuses on the R&D and production of pharmaceutical products in fields including dermatology, pediatrics, and gynecology. It also provides contract manufacturing services for various dosage forms such as granules, tablets, and syrups.

The company has established innovation platforms including a provincial-level enterprise technology center. Adhering to the strategy of integrating generic drug development with innovation-driven development, it has built a comprehensive R&D system and professional talent development system. The company has obtained 11 authorized invention patents, several of which have addressed domestic technological gaps, while some core products have achieved import substitution. It possesses 80 drug manufacturing approvals and 13 exclusive drug varieties/formulations, including 7 products listed in the National Medical Insurance Catalogue and 2 products listed in the National Essential Medicines List, demonstrating strong competitive advantages in its core fields.

Founded in 1998, the company is a modern enterprise engaged in the R&D and manufacturing of medical devices as well as a professional provider of overall smart medical system solutions. Committed to addressing medical gas supply and hospital-acquired infection issues, it supplies safe, stable, efficient and intelligent life support systems and designated life support areas for all types of medical institutions. Its core businesses cover the research, design, production, system integration, operation and maintenance services of medical gas equipment & systems, and medical clean equipment & systems.

The company is a large modern health and wellness technology enterprise integrating the R&D, production, sales, and health management services of various health products. Its business scope covers health foods, nutritional supplements, foods for special dietary uses, food-medicine homologous products, disinfectant products with Chinese regulatory approval, cosmeceuticals, household physical therapy equipment, traditional Chinese medicine wellness services, elderly wellness and care services, and other health-related fields.

Founded in September 2018 and located in Chengdu High-tech Zone, Sichuan Huashu Turing Additive Manufacturing Technology Co., Ltd. is an enterprise providing comprehensive medical 3D printing solutions. The company has an R&D facility of 3,140.56 square meters, equipped with a GMP-compliant research base and clean laboratories. It participated in the joint construction of the National Engineering Laboratory for Additive Manufacturing of Polymer Complex Structures and has been recognized as a National High-tech Enterprise and a Sichuan Specialized, Sophisticated, Special and Innovative SME.

The company focuses on the R&D, production, and sales of personalized medical devices, covering fields such as orthopedic implants, precision radiotherapy, orthoses, surgical guides, and anatomical models. Its core products include radiotherapy X-ray dose compensators, additively manufactured interbody fusion cages, pulmonary nodule localization models, and modular intracavitary guides for brachytherapy.

As of 2026, the company has filed 165 intellectual property applications, of which 101 have been granted, including 9 invention patents. It has obtained 28 medical device registration certificates and undertaken 23 provincial and municipal scientific research projects. The company achieved a compound annual growth rate of 65.4% over the past three years and has established joint research centers with more than 30 top-tier tertiary hospitals in China.

Nigale was co-founded by Sichuan Academy of Medical Sciences and its affiliated hospital in 1994. In January 2025, Nigale officially joined China Resources Pharmaceutical Group Limited.

Nigale is a high-tech enterprise integrating intelligent blood collection and transfusion equipment, smart medical consumables, and information integration and intelligent interaction technologies. It is among the first batch of Specialized, Sophisticated, Special and Innovative “Little Giant” Enterprises recognized in Sichuan Province, and was included in the second batch of such enterprises recognized by the Ministry of Industry and Information Technology (MIIT). It is also one of the first batch of Specialized, Sophisticated, Special and Innovative “Little Giant” Enterprises supported by the Chinese government for high-quality development, as well as a Sichuan Industrial Quality Benchmark Enterprise.

Nigale has established multiple innovation platforms, including the Sichuan Provincial Engineering Research Center, Sichuan Provincial Enterprise Technology Center, Chengdu Engineering Research Technology Center, Chengdu Academician (Expert) Innovation Workstation, and Chengdu Future Urban Scenario Laboratory. Multiple products have been recognized as National Key New Products and included in National Torch Plans and national innovation projects. By the end of 2025, Nigale had participated in the drafting of 13 national and industry standards, with 3 enterprise standards upgraded into national and industry standards. The company has obtained 352 intellectual property certificates, including 93 invention patents.

The company is a modern enterprise integrating the R&D, design, production and sales of medical supplies.

Its main products include medical masks, industrial protective masks, Class I and Class II medical devices, disposable sanitary products, personal protective products and labor protection supplies. The company’s mask material sales account for 40% of the global market share.

The company has independently developed 20 utility model patents and owns four brands, including Limei Hao Shenghuo, Limei, Huamianer and LMBH. Among them, the Huamianer brand holds a market share of up to 50% in Southwest China, with products distributed through multiple channels including supermarkets, hotels, maternal and infant stores, and other retail outlets.